Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on June 18, 2007

Hypertension. 2007
Published online before print June 18, 2007, doi: 10.1161/HYPERTENSIONAHA.107.091223
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Correction (v54,pe138)
Right arrow All Versions of this Article:
50/2/396    most recent
HYPERTENSIONAHA.107.091223v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franco, M. C.P.
Right arrow Articles by Sesso, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franco, M. C.P.
Right arrow Articles by Sesso, R.
Related Collections
Right arrow Clinical Studies
Right arrow Other etiology
Right arrow Endothelium/vascular type/nitric oxide

Homocysteine and Nitric Oxide Are Related to Blood Pressure and Vascular Function in Small-for-Gestational-Age Children

Maria C.P. Franco*; Elisa M.S. Higa; Vânia D’Almeida; Fernanda G. de Sousa; Ana L. Sawaya; Zuleica B. Fortes; and Ricardo Sesso

From the Division of Nephrology (M.C.P.F., E.M.S.H., R.S.), Division of Genetics (V.D., F.G.d.S.), and Department of Physiology (A.L.S.), School of Medicine, Federal University of São Paulo, São Paulo, Brazil; and the Department of Pharmacology (Z.B.F.), University of São Paulo, Biomedical Sciences Institute, São Paulo, Brazil.

* To whom correspondence should be addressed. E-mail: mdcfranco{at}nefro.epm.br.

Abstract--Leptin, homocysteine (Hcy), and C-reactive protein are risk factors potentially useful in predicting future cardiac events. These plasma biomarkers may participate in the regulation of cardiovascular function through an NO-dependent mechanism. Our purpose was to investigate whether alterations in C-reactive protein, Hcy, leptin, and NO are present in small-for-gestational-age children and to determine whether the levels of these plasma biomarkers are associated with birth weight, vascular function, and blood pressure. Concentrations of leptin, Hcy, C-reactive protein, and NO were measured in 69 children (36 boys and 33 girls; ages 8 to 13 years). Leptin (means difference: 1.4 ng/mL; 95% CI: 0.4 to 2.4) and Hcy (means difference: 0.9 µmol/L; 95% CI: 0.3 to 1.5) levels were significantly elevated in children born small for gestational age compared with those with appropriate birth weight. Nevertheless, NO (means difference: 342.9 µmol; 95% CI: 124.2 to 561.6) concentration was significantly reduced in small birth weight children, and the levels of C-reactive protein remained unchanged. There was a significant association between the circulating levels of both NO and Hcy with vascular function, as well as with blood pressure levels, in our population. Because both Hcy and NO are associated with a risk of cardiovascular disease, it is possible that part of the association of low birth weight with elevated risk for vascular and metabolic disease in later life is mediated by perturbation in pathways for these biomarkers.


Key words: homocysteine • NO • endothelium function • blood pressure • children